Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
艾拉片
- Development stage
- Phase 2
- Lead developer
- Simcere Pharmaceutical Group
- Administration
- Oral
01
Overview
**艾拉片** is an orally administered traditional Chinese medicine candidate developed by Wuhan Humanwell Hi-Tech Industry for **erectile dysfunction**. It was listed in the company's pipeline as a Class 1 traditional Chinese medicine product in Phase 2/3 development; no specific active constituents, molecular targets, or pharmacologic mechanism were publicly identified in the supplied pipeline information.
- Other names
- Aila Tablet艾拉
Beyond the preview
Go deeper on 艾拉片.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 艾拉片.